Evidence map›Paper›PMID 42439809›Full record

ReviewInfection and immunity2026

Bad bugs mean business: gastric cancer is an intended consequence of

Valerie P O'Brien

Abstract readReview
In one paragraph

Review in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Valerie P O'BrienBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, West Lafayette, Indiana, USA.ORCID 0000-0003-0502-2690

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDREW D MESECAR · 1985 to 2026
$43.4M
Investigating gastric inflammation and preneoplastic progression driven by Helicobacter pylori infectionR00CA263036 · NCI · PURDUE UNIVERSITY · PI Valerie Phoebe O'Brien · 2024 to 2026
$621k
NCI NIH HHS P30 CA023168NCI NIH HHS R00 CA263036NCI NIH HHS R00CA263036, P30CA023168V Foundation for Cancer Research V2025-030Walther Cancer Foundation
6 · The paper itself

Abstract

The bacterium

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAnimalsDisease Models, AnimalHost-Pathogen InteractionsHumansMetaplasiagastric cancerHelicobacter pylorimetaplasiapathogen-associated malignancy

Identifiers

PMID42439809
PMCPMC13459922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.